Prenetics, a health sciences company known for its medical and genetic testing services, has halted its Bitcoin investment strategy amid a downturn in cryptocurrency prices. The company announced earlier this year that it had begun acquiring Bitcoin as part of its treasury management plan.
The decision to pause Bitcoin purchases reflects broader challenges faced by digital-asset treasury firms during periods of declining crypto valuations. Market conditions have caused many companies to reassess their cryptocurrency holdings and investment strategies, especially amid ongoing volatility.
Prenetics’ move comes as several other firms in the digital-asset space have also scaled back or halted their Bitcoin buying activities. The trend signals increasing caution among companies holding cryptocurrencies as part of their corporate treasury amid current market uncertainties.
It remains unclear whether Prenetics plans to resume its Bitcoin acquisitions once market conditions improve. The company continues to focus on its core health sciences operations, with the crypto investment strategy now temporarily suspended.